Literature DB >> 1842377

Adenosquamous carcinoma of the prostate: a case report.

D M Devaney1, A Dorman, M Leader.   

Abstract

Mixed types of carcinoma of the prostate are rare. The majority of those described (22 cases) are examples of mixed adenocarcinoma and transitional cell carcinoma. Much more unusual is the mixed adenosquamous carcinoma, of which only three cases have been described. This report presents an additional case of the rare adenosquamous carcinoma of the prostate. It discusses the clinicopathologic features and the possible histogenesis of this tumor and suggests a role for stilbestrol in its development.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1842377     DOI： 10.1016/0046-8177(91)90014-g

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  6 in total

1.  Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Authors:  Mark P Labrecque; Ilsa M Coleman; Lisha G Brown; Lawrence D True; Lori Kollath; Bryce Lakely; Holly M Nguyen; Yu C Yang; Rui M Gil da Costa; Arja Kaipainen; Roger Coleman; Celestia S Higano; Evan Y Yu; Heather H Cheng; Elahe A Mostaghel; Bruce Montgomery; Michael T Schweizer; Andrew C Hsieh; Daniel W Lin; Eva Corey; Peter S Nelson; Colm Morrissey
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

2.  Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate.

Authors:  Jue Wang; Fen Wei Wang; Chad A Lagrange; George P Hemstreet
Journal:  Rare Tumors       Date:  2010-09-30

Review 3.  Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature.

Authors:  Nicoleta C Arva; Kasturi Das
Journal:  Diagn Pathol       Date:  2011-05-31       Impact factor: 2.644

4.  Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation.

Authors:  Fernando Munoz; Pierfrancesco Franco; Patrizia Ciammella; Mario Clerico; Mauro Giudici; Andrea Riccardo Filippi; Umberto Ricardi
Journal:  Radiat Oncol       Date:  2007-04-03       Impact factor: 3.481

Review 5.  Pathological transition as the arising mechanism for drug resistance in lung cancer.

Authors:  Yueqing Chen; Waiying Yvonne Tang; Xinyuan Tong; Hongbin Ji
Journal:  Cancer Commun (Lond)       Date:  2019-10-01

6.  Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.

Authors:  Junji Kitamura; Satoru Taguchi; Takatsugu Okegawa; Kazuki Honda; Toshihiko Kii; Yoshihiro Tomida; Ryuki Matsumoto; Naoki Ninomiya; Kazuki Masuda; Yu Nakamura; Tsuyoshi Yamaguchi; Manami Kinjo; Mitsuhiro Tambo; Aya Isomura; Akimasa Hayashi; Hiroshi Kamma; Eiji Higashihara; Junji Shibahara; Hiroshi Fukuhara
Journal:  BMC Med Genomics       Date:  2021-09-03       Impact factor: 3.063
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.